Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuro-oncology Treatment Strategies for Primary Glial Tumors.

Seminars in neurology - 1 Dec 2023

Santos-Pinheiro Fernando, Graber Jerome J

Abstract excerpt

Primary brain tumors underwent reclassification in the 2021 World Health Organization update, relying on molecular findings (especially isocitrate dehydrogenase mutations and chromosomal changes in 1p, 19q, gain of chromosome 7 and loss of chromosome 10). Newer entities have also been described including histone 3 mutant midline gliomas. These updated pathologic classifications improve prognostication and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma
Share to Isocitrate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Temozolomide

Source

Identifiers

PMID: 38096849
DOI: 10.1055/s-0043-1776764

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuro-oncology Treatment Strategies for Primary Glial Tumors.PMID 38096849Read ↗

Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.Semantic proximity Read ↗

World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.Semantic proximity Read ↗

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period.Semantic proximity Read ↗

Current Considerations in the Treatment of Grade 3 Gliomas.Semantic proximity Read ↗

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.Semantic proximity Read ↗

Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology.Semantic proximity Read ↗

Current and promising treatment strategies in glioma.Semantic proximity Read ↗

Primary brain tumours in adults.Semantic proximity Read ↗

SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).Semantic proximity Read ↗

Next generation neuro-oncology.Semantic proximity Read ↗

Management of glioblastoma: State of the art and future directions.Semantic proximity Read ↗

Congress of Neurological Surgeons Systematic Review and Evidence-based Guidelines Update on the Role of Neuropathology in the Management of Progressive Glioblastoma in AdultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.